Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis

European Journal of Neurology

Volumn 6, Issue 3, 1999, Pages 347-352

  Paź, Aleksandra ^a   Fiszer, Urszula ^b   Zaborski, Jacek ^b   Korlak, Janina ^b   Członkowski, Andrzej ^a   Członkowska, Anna ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Adhesion molecules; Multiple sclerosis; Peripheral blood granulocytes; Peripheral blood lymphocytes

Indexed keywords

CD14 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN; INTEGRIN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REMISSION; STATISTICAL ANALYSIS;

EID: 0032971009     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.630347.x     Document Type: Article

References (35)

1. Ager A, Callard R, Ezine S, Goyert SM, Todd III RF (1997). Immunology today, the immune receptor supplement 1997, 2nd edition. Elsevier: Cambridge, UK.
2. Albelda SM, Smith CW, Ward PA (1994). Adhesion molecules and inflammatory injury. FASEB J 8:504-512.
3. Antel JP, Owens T (1993). The attraction of adhesion molecules. Ann Neurol 34:123-124.
4. Bansil S, Troiano R, Rohowsky-Kochan C, Jotkowitz A, Dowling PC, Cook S (1994). Multiple sclerosis: pathogenesis and treatment. Semin Neurol 14:146-153.
5. Bongioanni P, Fioretti C, Vanacore R, Bianchi F, Lombardo F, Ambrogi F, Meucci G (1996). Lymphocytes subsets in multiple sclerosis. A study with two-colour fluorescence analysis. J Neurol Sci 139:71-77.
6. Calopa M, Bas J, Mestre M, Arbizu T, Peres J, Buendia E (1995). T-cell subsets in multiple sclerosis: a serial study. Acta Neurol Scand 92:361-368.
7. Capra R, Marciano N, Cotti-Cometti V, Vignolo LA, Benttinzioli M, Airo P, et al. (1992). Immunological and gandolinum - DTPA MRI evaluation of relapsing-remitting multiple sclerosis. Acta Neurol Scand 86:342-345.
8. Compston A (1983). Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 46:106-114.
9. Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R (1995). Alterations in levels of CD28-/CDS+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diag Lab Immunol 2:249-252.
10. Droogan AG, McMillan SA, Douglas JP, Hawkins SA (1996). Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J Neuroimmunol 88:185-191.
11. Frequin STFM, Lamers KJB, Borm GF, Barkhof F, Jongen PJH, Hommes O (1993). T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Acta Neurol Scand 88:80-86.
12. Girgrah N, Letarte M, Becker LH, Cruz TF, Theriault E, Moscarello M (1991). Localization of the CD44 glycoprotein to fibrous asctrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol 50:779-792.
13. Hafler DA, Weiner HL (1995). Immunologic mechanisms and therapy in multiple sclerosis. Immunul Rev 144:75-107.
14. Hartung HP, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners KH, Toyka KV (1995). Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45(suppl 6):S22-S32.
15. Hirsch RL, Ordonez J, Panitch HS, Johnson KP (1985). T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis. J Neuroimmunol 9:391-398.
16. Hohlfeld R (1997). Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120:865-916.
17. Horic S, Okubo Y, Hossain M, Momose T, Suzuki J, Isobe M, Sekiguchi M (1997). Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines. Immunology 90:301-307.
18. Huddlestonc JR, Oldstone MBA (1979). T supressor Tg lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis. J Immunol 123:1615-1618.
19. Hunter SF, Rodriguez M (1995). Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin Immunopathol 17:89-105.
20. Karlik SJ, Hyduk SJ, Rice GPA (1997). Adhesion molecules: an intriguing therapeutic target in MS. Int MS J 4:55-61.
21. KastrukofF LF, Paty DW (1984). A serial study of peripheral blood T lymphocytes subsets in relapsing-remitting multiple sclerosis. Ann Neurol 15:250-256.
22. Kreutzfelder E, Shen G, Bittorf M, Scheiermann N, Thraenhart O, Seidel D, Grosse-Wilde H (1992). Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur Neurol 32:190-194.
23. Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452.
24. Ludewig M (1993). Toxic quinones produced by mammalian defense cells - causative agents for autoimmune reactions? Med Hypotheses 41:375-377.
25. Munschauer FE, Hartrich LA, Stewart CC, Jacobs L (1995). Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and a little clinical disability as compared to controls. J Neuroimmunol 62:177-181.
26. Olsson T, Wang WZ, Hojeberg B, Kostulas V, Jiang YP, Anderson G, et al. (1990). Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 86:981-985.
27. Poser CM, Paty DW, Scheinberg L, et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231.
28. Raine CS, Cannela B (1992). Adhesion molecules and central nervous system inflammation. Semin Neurosci 4:201-211.
29. Rose LM, Ginsberg AH, Rothstein TL, et al. (1988). Fluctuations of CD4+ T cells subsets in remitting-relapsing multiple sclerosis. Ann Neurol 24:192-199.
30. Springer TA (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314.
31. Storch M, Lassmann H (1997). Pathology and pathogenesis of demyelinating diseases. Curr Opinion Neurol 10:186-192.
32. Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M, Stemme S (1993). Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 34:155-161.
33. Thompson AJ, Brazil J, Martin EA (1985). Suppressor T cell changes in active multiple sclerosis. Analysis with three different monoclonal antibodies. J Neurol Neurosurg Psychiatry 48:1062-1064.
34. Van den Noort S, Frohman TC, Frohman EM, Gupta S (1989). T Lymphocytes from MS patients express greater amounts of ICAM-1 compared to T lymphocytes derived from normal controls. Neurology 39(suppl 1):173.
35. Violette SM, Rusche JR, Purdy SR, Boyd JG, Cos J, Silver S (1995). Differences in the binding of blocking anti-CD11b monoclonal antibodies to the A-domain of CD11b. J Immunol 155:3092-3101.